BIOGEN INC.

CAMBRIDGE, MA How do I update this listing?

Biogen is based out of Cambridge. Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The products of the Company include AVONEX, RITUXAN, TYSABRI and FUMADERM. The Company's products address diseases, such as multiple sclerosis (MS), non-Hodgkin's lymphoma (NHL), rheumatoid arthritis (RA), Crohn's disease (CD) and psoriasis. In addition to the marketed products, Biogen Idec has a number of product candidates in or near registrational stage development. It includes BG-12, Daclizumab, Fampridine, GA101, Humanized Anti-CD20 MAb (ocrelizumab), Lixiavaptan, Long-Acting rFactor IX and PEGylated interferon beta-1a. In December 2010, the Company and Neurimmune Holding AG announced that the Company had acquired a subsidiary of Neurimmune Holding AG.Whalewisdom has at least 4 13D filings, 12 13G filings, and 409 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Alert

Contact Info

biogen inc.
225 BINNEY STREET
CAMBRIDGE MA    02142

Business Phone: 7814642000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Denali Therapeutics Inc (DNLI) HEALTH CARE 13,310,253 1,114,866,791.28 1 13G 2020-09-22
Sage Therapeutics Inc (SAGE) HEALTH CARE 6,241,473 539,949,829.23 2 13G 2020-12-31
Nightstar Therapeutics PLC ADR (NITE) HEALTH CARE 20,638,209 524,416,890.69 3 13D 2019-03-04
Sangamo Therapeutics Inc (SGMO) HEALTH CARE 24,420,157 381,198,650.77 4 13G 2020-04-08
Solid Biosciences Inc (SLDB) HEALTH CARE 1,772,464 13,435,277.12 5 13G 2018-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments